机构:[1]Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan, China.[2]Department of Neurosurgery, Affiliated Hospital of Southwest Jiaotong University, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Research Project of the
General Hospital of Western Theater Command (2021–XZYG–
A13 and 2021–XZYG–C37) and the Spark Talent program to QO-Y
of General Hospital of the Western Theater Command.
第一作者机构:[1]Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan, China.[2]Department of Neurosurgery, Affiliated Hospital of Southwest Jiaotong University, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
通讯作者:
通讯机构:[1]Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan, China.[2]Department of Neurosurgery, Affiliated Hospital of Southwest Jiaotong University, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
推荐引用方式(GB/T 7714):
Yang Yuting,Hu Fei,Wu Song,et al.Blood-based biomarkers: diagnostic value in brain tumors (focus on gliomas)[J].Frontiers in neurology.2023,14:1297835.doi:10.3389/fneur.2023.1297835.
APA:
Yang Yuting,Hu Fei,Wu Song,Huang Zhangliang,Wei Kun...&Ou-Yang Qing.(2023).Blood-based biomarkers: diagnostic value in brain tumors (focus on gliomas).Frontiers in neurology,14,
MLA:
Yang Yuting,et al."Blood-based biomarkers: diagnostic value in brain tumors (focus on gliomas)".Frontiers in neurology 14.(2023):1297835